Community Clinical Oncology Program (CCOP) Changes its Name to Metro-Minnesota Community Oncology Research Consortium (MMCORC)
Organization introduces new name and new logo, but carries on its legacy of community-wide cancer research
MINNEAPOLIS, Minn.–The Community Clinical Oncology Program (CCOP), a Twin Cities-based cancer research group, announces it has changed its name to the Metro-Minnesota Community Oncology Research Consortium (MMCORC).The new name better reflects its mission of cooperation among clinical research organizations in the Twin Cities and surrounding communities.
The MMCORC is a nonprofit research program sponsored by the National Cancer Institute (NCI) and participating community hospitals and clinics. This program gives cancer patients access to the newest therapies for cancer treatment, symptom management and cancer prevention.
The MMCORC is one of the largest and most successful community oncology research consortiums in the nation. It has been providing cancer patients in Minnesota the opportunity to participate in crucial clinical trials close to home for 30 years. On average, 500 patients are enrolled in trials every year, contributing to the many advances in cancer treatment and control used today.
“The MMCORC is an incredibly valuable resource for the cancer patients in our communities,” said Joseph Leach, MD, of Minnesota Oncology and MMCORC Principal Investigator. “Many of the life-saving treatments now available are due to the research conducted by this consortium.”
In recognition of the MMCORC’s work, NCI recently awarded itan$11.5 million grant that will be used to conduct clinical trials and research studies aimed at improving patient outcomes and reducing health disparities.
Locally, the MMCORC is a unique collaboration of competing health care systems in the metropolitan area and beyond. Its membership includes 20 hospitals and clinics locally as well as rural sites in Stillwater, Willmar, New Ulm and New Richmond, Wisconsin. More than 160 physicians and providers volunteer their time and expertise to make the MMCORC a nationally recognized model of how multiple health care systems can come together for the greater good of patient care.
“I’m pleased to be a part of an organization in which so many different doctors and health systems collaborate to provide the latest cutting-edge treatments to our patients,” says Daniel Anderson, MD, of HealthPartners and MMCORC Associate Principal Investigator. “We are truly fortunate to have such a strong culture of cancer research in the Twin Cities region.”
About Metro-Minnesota Community Oncology Research Consortium
The Metro-Minnesota Community Oncology Research Consortium (MMCORC) is a consortium of 20hospitals and clinics that bring the advantages of cancer research to the community. The nonprofit organization is sponsored by the National Cancer Institute (NCI) and participating hospitals and clinics. More than 160 physician-investigators participate in MMCORC’s cancer research. For more information, visit mmcorc.org or call the administrative office at 952-993-1517.
